Healthcare provider profile · identity verified

Scott John Dierks, MD

Family Practice · SIOUX FALLS, SD · NPI 1063438968

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	416	106
Lisinopril	Lisinopril	303	74
Omeprazole	Omeprazole	296	70
Losartan Potassium	Losartan Potassium	290	66
Amlodipine Besylate	Amlodipine Besylate	256	65
Levothyroxine Sodium	Levothyroxine Sodium	230	48
Tamsulosin Hcl	Tamsulosin Hcl	204	57
Rosuvastatin Calcium	Rosuvastatin Calcium	199	48
Gabapentin	Gabapentin	190	34
Hydrochlorothiazide	Hydrochlorothiazide	158	42
Simvastatin	Simvastatin	155	39
Fluoxetine Hcl	Fluoxetine Hcl	126	26
Furosemide	Furosemide	126	31
Metoprolol Succinate	Metoprolol Succinate	123	29
Metformin Hcl	Metformin Hcl	114	29
Meloxicam	Meloxicam	106	26
Pantoprazole Sodium	Pantoprazole Sodium	98	24
Sertraline Hcl	Sertraline Hcl	98	18
Ozempic	Semaglutide	87	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	86	21
Alendronate Sodium	Alendronate Sodium	72	21
Montelukast Sodium	Montelukast Sodium	72	18
Albuterol Sulfate Hfa	Albuterol Sulfate	66	26
Baclofen	Baclofen	65	17
Allopurinol	Allopurinol	62	17
Pravastatin Sodium	Pravastatin Sodium	57	15
Pregabalin	Pregabalin	57	13
Trazodone Hcl	Trazodone Hcl	56	15
Prednisone	Prednisone	54	41
Celecoxib	Celecoxib	53	17
Warfarin Sodium	Warfarin Sodium	53	suppressed
Spironolactone	Spironolactone	52	13
Duloxetine Hcl	Duloxetine Hcl	51	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	13
Potassium Chloride	Potassium Chloride	49	17
Metformin Hcl Er	Metformin Hcl	47	12
Zolpidem Tartrate	Zolpidem Tartrate	47	suppressed
Clopidogrel	Clopidogrel Bisulfate	44	suppressed
Amoxicillin	Amoxicillin	43	28
Citalopram Hbr	Citalopram Hydrobromide	43	suppressed
Finasteride	Finasteride	43	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	43	11
Bupropion Xl	Bupropion Hcl	42	11
Donepezil Hcl	Donepezil Hcl	42	suppressed
Carvedilol	Carvedilol	41	13
Mounjaro	Tirzepatide	39	suppressed
Eliquis	Apixaban	38	12
Fluticasone Propionate	Fluticasone Propionate	38	suppressed
Naproxen	Naproxen	38	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	37	suppressed
Chlorthalidone	Chlorthalidone	36	suppressed
Lansoprazole	Lansoprazole	36	suppressed
Buspirone Hcl	Buspirone Hcl	35	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	suppressed
Glipizide	Glipizide	33	suppressed
Clonazepam	Clonazepam	32	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Azithromycin	Azithromycin	28	28
Famotidine	Famotidine	28	13
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Methylprednisolone	Methylprednisolone	26	26
Benazepril Hcl	Benazepril Hcl	25	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Atenolol	Atenolol	23	suppressed
Cefdinir	Cefdinir	23	19
Farxiga	Dapagliflozin Propanediol	23	suppressed
Lorazepam	Lorazepam	23	suppressed
Cephalexin	Cephalexin	22	18
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	19
Ezetimibe	Ezetimibe	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	15
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Diazepam	Diazepam	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Valsartan	Valsartan	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	11
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Propafenone Hcl	Propafenone Hcl	12	suppressed
Tiadylt Er	Diltiazem Hcl	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Propranolol Hcl	Propranolol Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error